# A Bleeding-Model Clinical Study

> **NCT05916508** · NA · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 90 (actual)

## Conditions studied

- Gingivitis

## Interventions

- **DRUG:** 0.454% stannous fluoride
- **DRUG:** 0.76% sodium monofluorophosphate
- **DRUG:** 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM

## Key facts

- **NCT ID:** NCT05916508
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2020-11-20
- **Final completion:** 2020-11-20
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05916508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05916508, "A Bleeding-Model Clinical Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05916508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*